Optimizing polypharmacy among elderly hospital patients with chronic diseases-study protocol of the cluster randomized controlled POLITE-RCT trial

Implementation Science

Volumn 9, Issue 1, 2014, Pages

  Löffler, Christin ^a   Drewelow, Eva ^a   Paschka, Susanne D ^a   Frankenstein, Martina ^a   Eger, Julia ^a   Jatsch, Lisa ^a   Reisinger, Emil C ^a   Hallauer, Johannes F ^b   Drewelow, Bernd ^a   Heidorn, Karen ^a   Schröder, Helmut ^c   Wollny, Anja ^a   Kundt, Günther ^a   Schmidt, Christian ^a   Altiner, Attila ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^b Institute of Pathology   (Germany)

^c Wissenschaftliches Institut der AOK WIdO   (Germany)

Author keywords

Drug utilization review; Inappropriate prescribing; Patient centered care; Polypharmacy; Primary health care; Secondary care

Indexed keywords

PRESCRIPTION DRUG;

AGED; CHRONIC DISEASE; CLINICAL TRIAL; CLUSTER ANALYSIS; CONTROLLED STUDY; GERMANY; HOSPITALIZATION; HUMAN; LONG TERM CARE; MULTICENTER STUDY; PATIENT SATISFACTION; POLYPHARMACY; RANDOMIZED CONTROLLED TRIAL; STATISTICS AND NUMERICAL DATA;

AGED; CHRONIC DISEASE; CLUSTER ANALYSIS; GERMANY; HOSPITALIZATION; HUMANS; LONG-TERM CARE; PATIENT SATISFACTION; POLYPHARMACY; PRESCRIPTION DRUGS;

EID: 84907959165     PISSN: None     EISSN: 17485908     Source Type: Journal    
DOI: 10.1186/s13012-014-0151-7     Document Type: Article

References (62)

1. Casselli G, Mesle F, Vallin J. Epidemiologic transition theory exceptions. Genus: J Popul Sci 2002, 9:9-51.
2. Harper K, Armelagos G. The changing disease-shape in the third epidemiological transition. Int J Environ Res Public Health 2010, 7(2):675-697. 10.3390/ijerph7020675, 20616997.
3. Schäfer I, von Leitner EC, Schön G, Koller D, Hansen H, Kolonko T, Kaduszkiewicz H, Wegscheider K, Glaeske G, van den Bussche H. Multimorbidity patterns in the elderly: a new approach of disease clustering identifies complex interrelations between chronic conditions. PLoS One 2010, 5(12):e15941. 10.1371/journal.pone.0015941, 21209965.
4. Bregnhøj L, Thirstrup S, Kristensen MB, Bjerrum L, Sonne J. Combined intervention programme reduces inappropriate prescribing in elderly patients exposed to polypharmacy in primary care. Eur J Clin Pharmacol 2009, 65:199-207. 10.1007/s00228-008-0558-7, 18807252.
5. Denneboom W, Dautzenberg M, Grol R, De Smet P. Treatment reviews of older people on polypharmacy in primary care: cluster controlled trial comparing two approaches. Br J Gen Prac 2007, 57(542):723-731.
6. Heppner HJ, Christ M, Gosch M, Mühlberg W, Bahrmann P, Bertsch T, Sieber C, Singler K. Polypharmacy in the elderly from the clinical toxicologist perspective. Z Gerontol Geriatr 2012, 45(6):473-478. 10.1007/s00391-012-0383-6, 22915001.
7. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005, 294(6):716-724. 10.1001/jama.294.6.716, 16091574.
8. Manhart A, Geerdes-Fenge H, Drewelow E, Löffler C, Reisinger E, Heidorn K, Drewelow B, Kundt G, Altiner A. Verminderung von Polypharmazie bei Patienten mit chronischen Erkrankungen (POLITE). Abschlussbericht für das Ministerium für Arbeit, Gleichstellung und Soziales: Innovative Projekte zur Anpassung der Versorgung an die demografische Entwicklung in Mecklenburg-Vorpommern 2012,
9. Junius-Walker U, Theile G, Hummers-Pradier E. Prevalence and predictors of polypharmacy among older primary care patients in Germany. Fam Pract 2007, 24(1):14-19. 10.1093/fampra/cml067, 17164234.
10. Maher RL, Hanlon JT, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf 2014, 13(1):57-65. 10.1517/14740338.2013.827660, 24073682.
11. Walsh EK, Cussen K. " Take ten minutes" : a dedicated ten minute medication review reduces polypharmacy in the elderly. Ir Med J 2010, 103(8):236-238. 21046863.
12. Maeda K. Systematic review of the effects of improvement of prescription to reduce the number of medications in the elderly with polypharmacy. Yakugaku Zasshi 2009, 129(5):631-645. 10.1248/yakushi.129.631, 19420895.
13. Schnurrer JU, Frölich JC. Zur Häufigkeit und Vermeidbarkeit von tödlichen unerwünschten Arzneimittelwirkungen. Internist 2003, 44(7):889-895. 10.1007/s00108-003-0988-3, 14631585.
14. Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med 2010, 170(18):1648-1654. 10.1001/archinternmed.2010.355, 20937924.
15. Vass M, Hendriksen C. Polypharmacy and other people-the GP perspective. Z Gerontol Geriatr 2005, 38(Suppl 1):I14-I17. 10.1007/s00391-005-1104-1, 16189730.
16. Ostini R, Hegney D, Jackson C, Williamson M, Mackson JM, Gurman K, Hall W, Tett SE. Systematic review of interventions to improve prescribing. Ann Pharmacother 2009, 43(5):502-513. 10.1345/aph.1L488, 19261953.
17. Grindrod KA, Patel P, Martin JE. What interventions should pharmacists employ to impact health practitioners' prescribing practices?. Ann Pharmacother 2006, 40(9):1546-1557. 10.1345/aph.1G300, 16896025.
18. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003, 22:2716-2724. 10.1001/archinte.163.22.2716.
19. Sönnichsen A. Polypharmakotherapie - mehr Medikamente, weniger Gesundheit?. Z Allg Med 2011, 3:108-110.
20. Kaduszkiewicz H, Stolzenbach CO, Reich CA, Schäfer I, van den Bussche H, Streich W, Abholz HH, Steinmann S, Wiese B, Löffler C, Altiner A. Wie lässt sich das Chronic Care Model in die hausärztliche Versorgung umsetzen? Presentation and Poster, Colloquium of the BMBF research network " Health in old age" , Berlin 1 2010,
21. Resnick B, Fick DM. 2012 Beers criteria update: how should practicing nurses use the criteria?. Geriatr Nurs 2012, 33(4):253-255. 10.1016/j.gerinurse.2012.06.001, 22841457.
22. Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 2010, 107(31-32):543-551. 20827352.
23. Amann U, Schmedt N, Garbe E. Prescribing of potentially inappropriate medications for the elderly: an analysis based on the PRISCUS list. Dtsch Arztebl Int 2012, 109(5):69-75. 22368709.
24. Härtel U, Volger E. Inanspruchnahme und Akzeptanz klassischer Naturheilverfahren und alternativer Heilmethoden in Deutschland - Ergebnisse einer repräsentativen Bevölkerungsstudie. Forsch Komplementarmed Klass Naturheilkd 2004, 11(6):327-334. 10.1159/000082814, 15604623.
25. Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract 2005, 17(4):123-132. 10.1111/j.1041-2972.2005.0020.x, 15819637.
26. Yuan C-S, Wei G, Dey L, Karrison T, Nahlik L, Maleckar S, Kasza K, Ang-Lee M, Moss J. Brief communication: American ginseng reduces warfarin's effect in healthy patients. Ann Intern Med 2004, 141(1):23-27. 10.7326/0003-4819-141-1-200407060-00011, 15238367.
27. Bayer Pharma AG: Fachinformation Xarelto® Bayer Vital GmbH. Berlin: 2014..
28. Gallagher P, O'Mahony D. STOPP (Screening Tool of Older Persons' potentially inappropriate prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008, 37(6):673-679. 10.1093/ageing/afn197, 18829684.
29. Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, Cowper PA, Landsman PB, Cohen HJ, Feussner JR. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996, 100(4):428-437. 10.1016/S0002-9343(97)89519-8, 8610730.
30. Jameson JP, VanNoord GR. Pharmacotherapy consultation on polypharmacy patients in ambulatory care. Ann Pharmacother 2001, 35(7-8):835-840. 10.1345/aph.10259, 11485129.
31. Blenkinsopp A, Bond C, Raynor D. Medication reviews. Br J Clin Pharmacol 2012, 74(4):573-580. 10.1111/j.1365-2125.2012.04331.x, 22607195.
32. Meyer TJ, van Kooten D, Marsh S, Prochazka AV. Reduction of polypharmacy by feedback to clinicians. J Gen Intern Med 1991, 6(2):133-136. 10.1007/BF02598309, 2023020.
33. Williams ME, Pulliam CC, Hunter R, Johnson TM, Owens JE, Kincaid J, Porter C, Koch G. The short-term effect of interdisciplinary medication review on function and cost in ambulatory elderly people. J Am Geriatr Soc 2004, 52(1):93-98. 10.1111/j.1532-5415.2004.52016.x, 14687321.
34. Lampela P, Hartikainen S, Lavikainen P, Sulkava R, Huupponen R. Effects of medication assessment as part of a comprehensive geriatric assessment on drug use over a 1-year period: a population-based intervention study. Drugs Aging 2010, 27(6):507-521. 10.2165/11536650-000000000-00000, 20524710.
35. Pitkala KH, Strandberg TE, Tilvis RS. Is it possible to reduce polypharmacy in the elderly? A randomised controlled trial. Drugs Aging 2001, 18(2):143-149. 10.2165/00002512-200118020-00007, 11346128.
36. Kroenke K, Pintholt EM. Reducing polypharmacy in the elderly. A controlled trial of physician feedback. J Am Geriatr Soc 1990, 38(1):31-36. 2404053.
37. Anthierens S, Tansens A, Petrovic M, Christiaens T. Qualitative insights into general practitioners views on polypharmacy. BMC Fam Pract 2010, 11:65. 10.1186/1471-2296-11-65, 20840795.
38. Patterson SM, Hughes C, Kerse N, Cardwell CR, Bradley MC. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2012, 5:CD008165. 22592727.
39. Tamblyn R. Medication use in seniors: challenges and solutions. Therapie 1996, 51:269-282. 8881121.
40. Borne R, Cumbler E, Glasheen JJ. Reducing polypharmacy: is hospitalization the right time?. Arch Intern Med 2011, 171(9):869. 10.1001/archinternmed.2011.208, 21555674.
41. Drewelow E, Manhart A, Geerdes-Fenge H, Heidorn K, Drewelow B, Altiner A, Reisinger E. Pilotstudie zur Optimierung der Schnittstelle aus der sekundären in die primäre Krankenversorgung zur Reduktion von Polypharmazie (POLITE). Z Allg Med 2012; 88 (ZFA Hauptprogramm + Abstractband 2012); Posterbeitrag des 46 2012, Rostock, DEGAM Kongresses.
42. Clyne W, Blenkinsopp A, Seal R. A Guide to Medication Review 2008, National Prescribing Centre, Liverpool.
43. Greenhalgh T, Hurwitz B. Narrative based medicine: why study narrative?. BMJ 1999, 318(7175):48-50. 10.1136/bmj.318.7175.48, 9872892.
44. Greenhalgh T. Narrative based medicine: narrative based medicine in an evidence based world. BMJ 1999, 318(7179):323-325. 10.1136/bmj.318.7179.323, 9924065.
45. Seidling HM, Schmitt SP, Bruckner T, Kaltschmidt J, Pruszydlo MG, Senger C, Bertsche T, Walter-Sack I, Haefeli WE. Patient-specific electronic decision support reduces prescription of excessive doses. Qual Saf Health Care 2010, 19(5):1-7.
46. Moock J. Präferenzbasierte Lebensqualitätsmessung: Der EQ-5D Fragebogen. Phys Med Rehab Kuror 2008, 18:245-249. 10.1055/s-0028-1082329.
47. Szende A, Oppe M, Devlin N. Hrsg. EQ-5D Value Sets: Inventory, Comparative Review and User Guide 2007, Springer, Dordrecht.
48. Greiner W, Claes C, Busschbach JJV, von der Schulenburg JM. Validating the EQ-5D with time trade off for the German population. Eur J Health Econ 2005, 6(2):124-130. 10.1007/s10198-004-0264-z, 19787848.
49. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine Arch Intern Med 1991, 151(9):1825-1832.
50. Schwalbe O, Freiberg I, Kloft C. Die Beers-Liste. Ein Instrument zur Optimierung der Arzneimitteltherapie geriatrischer Patienten. Med Monatsschr Pharm 2007, 30:244-248. 17711044.
51. Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, Cohen HJ, Feussner JR. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992, 45(10):1045-1051. 10.1016/0895-4356(92)90144-C, 1474400.
52. Samsa GP, Hanlon JT, Schmader KE, Weinberger M, Clipp EC, Uttech KM, Lewis IK, Landsman PB, Cohen HJ. A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol 1994, 47(8):891-896. 10.1016/0895-4356(94)90192-9, 7730892.
53. Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, Rowland CR. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004, 2:12. 10.1186/1477-7525-2-12, 14987333.
54. Atkinson MJ, Kumar R, Cappelleri JC, Hass SL. Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value Health 2005, 8(Suppl 1):S9-S24. 10.1111/j.1524-4733.2005.00066.x, 16336491.
55. Kriston L, Scholl I, Hölzel L, Simon D, Loh A, Härter M. The 9-item Shared Decision Making Questionnaire (SDM-Q-9). Development and psychometric properties in a primary care sample. Patient Educ Couns 2010, 80(1):94-99. 10.1016/j.pec.2009.09.034, 19879711.
56. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969, 9(3):179-186. 10.1093/geront/9.3_Part_1.179, 5349366.
57. Robertson MC, Devlin N, Gardner MM, Campbell AJ. Effectiveness and economic evaluation of a nurse delivered home exercise programme to prevent falls 1: randomised controlled trial. BMJ 2001, 322:697-701. 10.1136/bmj.322.7288.697, 11264206.
58. Jöckel KH, Babitsch B, Bellach BM, Bloomfield K, Hoffmeyer-Zlotnik J, Winkler J, Wolf C. Empfehlungen der Arbeitsgruppe " Epidemiologische Methoden" in der Deutschen Arbeitsgemeinschaft Epidemiologie der GMDS und der DGSMP zur Messung und Quantifizierung soziodemographischer Merkmale in epidemiologischen Studien. Hrsg 1998, Messung soziodemographischer Merkmale in der Epidemiologie, München, Ahrens W.
59. Altiner A, Brockmann S, Sielk M, Wilm S, Wegscheider K, Abholz HH. Reducing antibiotic prescriptions for acute cough by motivating GPs to change their attitudes to communication and empowering patients: a cluster-randomized intervention study. J Antimicrob Chemother 2007, 60(3):638-644. 10.1093/jac/dkm254, 17626023.
60. Campbell MK, Mollison J, Steen N, Grimshaw JM, Eccles M. Analysis of cluster randomized trials in primary care: a practical approach. Fam Pract 2000, 17(2):192-196. 10.1093/fampra/17.2.192, 10758085.
61. Campbell MJ, Donner A, Klar N. Developments in cluster randomized trials and Statistics in Medicine. Stat Med 2007, 26(1):2-19. 10.1002/sim.2731, 17136746.
62. Muth E, Scholz R, Kruse A, Doblehammer G. Der demografische Wandel in Mecklenburg-Vorpommern - Veränderung der Altersstruktur, demografische Alterung und Schrumpfung von 1982 bis 2007 2010, Statistische Hefte, StatA MV.